By Max Schlather,
Managing Director, Strategy, Clarity Insights. Mr. Schlather has significant experience across complex healthcare information management and analytics programs with the goal of advancing business capabilities. He has worked at regional health systems, retail pharmacies, and national and regional health plans. He delivers value to clients through projects across the continuum of strategy to implementation, helping turn clinical, financial and operational data into insights.

Health Innovation Lead Max Schlather sees Silicon Valley giving the healthcare industry a needed wake-up call. He shared his thoughts in an editorial on Healthcare Analytics News. Check it out below.

When Amazon, Berkshire Hathaway and JPMorgan Chase announced their healthcare partnership earlier this year, it signaled that the companies were taking action on a reality some of us have known for years: The healthcare industry isn’t just primed for disruption — healthcare needs disruption. Since then, we’ve seen Amazon, Alphabet, IBM, Microsoft and Salesforce make a joint statement in support of FHIR (Fast Healthcare Interoperability Resources) at the Blue Button 2.0 Developer conference, coming together to push for interoperability, a change that will make the market a friendlier place for the companies and their ambitions.

And we’ve wanted interoperability, too. Those of us in positions to see the whole of the healthcare ecosystem have a unique view of the medical-industrial complex that has been established. Holistically, the players in the market want to reduce costs, increase quality and improve outcomes; at a high level, there is consensus. Click to read the rest at Healthcare Analytics News.

You may also like:


Is Interoperability in Healthcare Still That Controversial? Why FHIR 4 is a Big Step Forward

When it comes to the exchange of data, application interoperability is crucial. That’s why 2019's debut of FHIR 4 – anno...